Document Detail


Omega-3 fatty acids: how can they be used in secondary prevention?
MedLine Citation:
PMID:  18937899     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Omega-3 fatty acids (FAs) are divided into long-chain fatty acids (eicosapentaenoic acid and docosahexaenoic acid ), which are found in fatty fish, and intermediate-chain FAs (alpha-linolenic acid), which are found in vegetable oils. Omega-3 FAs favorably modulate a variety of vascular risk factors and also exert antiarrhythmic effects. Epidemiologic data suggest that increased consumption of marine omega-3 FAs is associated with reduced coronary heart disease (CHD) mortality. Randomized controlled studies also show that supplementation with EPA and DHA reduces CHD risk, primarily in the secondary prevention setting. Data are more limited on the efficacy of marine omega-3 FAs for the primary prevention of CHD and on the role of alpha-linolenic acid. Increased intake of EPA and DHA represents a valuable tool for vascular disease prevention and should be recommended in all patients with CHD.
Authors:
Konstantinos Tziomalos; Vasilios G Athyros; Asterios Karagiannis; Dimitri P Mikhailidis
Related Documents :
14961279 - Screening of red algae filaments as a potential alternative source of eicosapentaenoic ...
16566089 - Fatty acids from lipids of marine organisms: molecular biodiversity, roles as biomarker...
12596859 - Incorporation and accumulation of docosahexaenoic acid from the medium by pichia methan...
7979549 - Effect of dietary omega-3 and omega-6 fatty acid sources on puva-induced cutaneous toxi...
3789659 - Comparative changes in the fatty-acid composition of rat cardiac phospholipids after lo...
8517859 - Kinetics of the inhibition of tumour growth in mice by eicosapentaenoic acid-reversal b...
229899 - Denaturation of thermophilic ferricytochrome c-552 by acid, guanidine hydrochloride, an...
10805569 - Cd45 tyrosine phosphatase inhibitory components from aspergillus niger.
15915449 - Quantitative analysis of 23-hydroxybetulinic acid in mouse plasma using electrospray li...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current atherosclerosis reports     Volume:  10     ISSN:  1534-6242     ISO Abbreviation:  Curr Atheroscler Rep     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2008-10-21     Completed Date:  2009-01-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897685     Medline TA:  Curr Atheroscler Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  510-7     Citation Subset:  IM    
Affiliation:
Second Propedeutic Department of Internal Medicine, Aristotle University, Hippokration Hospital, 63 Solonos Street, Thessaloniki, 54248, Greece. ktziomalos@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / therapeutic use
Coronary Disease / prevention & control*
Fatty Acids, Omega-3 / therapeutic use*
Humans
Meta-Analysis as Topic
Secondary Prevention
Vascular Diseases / prevention & control
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Fatty Acids, Omega-3

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart ...
Next Document:  The mediterranean diet: rationale and evidence for its benefit.